Palapas, Nestor H.
HRN: 22-95-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/23/2023
04/30/2023
IV
600mg
Q8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueCardiovascularProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes